BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

Name: Work Video:
Duration: 3 min 30 s
Scott M. Wilhelm; Christopher Carter; LiYa Tang; Dean Wilkie; Angela McNabola; Hong Rong; Charles Chen; Xiaomei Zhang; Patrick W. Vincent; Mark McHugh; Yichen Cao; Jaleel Shujath; Susan L. Gawlak; Deepa Eveleigh; Bruce R. Rowley; Li Liu; Lila Adnane; Mark Lynch; Daniel Auclair; I Taylor; Rich Gedrich; Andrei Voznesensky; Bernd Riedl; Leonard Post; Gideon Bollag; Pamela A. Trail
{'id': 'https://openalex.org/W2140765540', 'doi': 'https://doi.org/10.1158/0008-5472.can-04-1443', 'title': 'BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis', 'display_name': 'BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis', 'publication_year': 2004, 'publication_date': '2004-10-01', 'ids': {'openalex': 'https://openalex.org/W2140765540', 'doi': 'https://doi.org/10.1158/0008-5472.can-04-1443', 'mag': '2140765540', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/15466206'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/0008-5472.can-04-1443', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5109717943', 'display_name': 'Scott M. Wilhelm', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I67348948', 'display_name': 'Bayer (Germany)', 'ror': 'https://ror.org/04hmn8g73', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I67348948']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Scott M. Wilhelm', 'raw_affiliation_strings': ['Bayer Pharmaceuticals Corporation, West Haven, Connecticut 06516, USA.'], 'affiliations': [{'raw_affiliation_string': 'Bayer Pharmaceuticals Corporation, West Haven, Connecticut 06516, USA.', 'institution_ids': ['https://openalex.org/I67348948']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5000584525', 'display_name': 'Christopher Carter', 'orcid': 'https://orcid.org/0000-0003-1368-4205'}, 'institutions': [{'id': 'https://openalex.org/I4210093361', 'display_name': 'Biohaven Pharmaceuticals (United States)', 'ror': 'https://ror.org/00m2ky193', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210093361']}, {'id': 'https://openalex.org/I150569930', 'display_name': 'Bayer (United States)', 'ror': 'https://ror.org/034ffbg36', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I150569930', 'https://openalex.org/I67348948']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Christopher Carter', 'raw_affiliation_strings': ['1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and'], 'affiliations': [{'raw_affiliation_string': '1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and', 'institution_ids': ['https://openalex.org/I4210093361', 'https://openalex.org/I150569930']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5090677260', 'display_name': 'LiYa Tang', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210093361', 'display_name': 'Biohaven Pharmaceuticals (United States)', 'ror': 'https://ror.org/00m2ky193', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210093361']}, {'id': 'https://openalex.org/I150569930', 'display_name': 'Bayer (United States)', 'ror': 'https://ror.org/034ffbg36', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I150569930', 'https://openalex.org/I67348948']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'LiYa Tang', 'raw_affiliation_strings': ['1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and'], 'affiliations': [{'raw_affiliation_string': '1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and', 'institution_ids': ['https://openalex.org/I4210093361', 'https://openalex.org/I150569930']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5042590198', 'display_name': 'Dean Wilkie', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I150569930', 'display_name': 'Bayer (United States)', 'ror': 'https://ror.org/034ffbg36', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I150569930', 'https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I4210093361', 'display_name': 'Biohaven Pharmaceuticals (United States)', 'ror': 'https://ror.org/00m2ky193', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210093361']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Dean Wilkie', 'raw_affiliation_strings': ['1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and'], 'affiliations': [{'raw_affiliation_string': '1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and', 'institution_ids': ['https://openalex.org/I150569930', 'https://openalex.org/I4210093361']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5043919144', 'display_name': 'Angela McNabola', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210093361', 'display_name': 'Biohaven Pharmaceuticals (United States)', 'ror': 'https://ror.org/00m2ky193', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210093361']}, {'id': 'https://openalex.org/I150569930', 'display_name': 'Bayer (United States)', 'ror': 'https://ror.org/034ffbg36', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I150569930', 'https://openalex.org/I67348948']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Angela McNabola', 'raw_affiliation_strings': ['1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and'], 'affiliations': [{'raw_affiliation_string': '1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and', 'institution_ids': ['https://openalex.org/I4210093361', 'https://openalex.org/I150569930']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109052700', 'display_name': 'Hong Rong', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210093361', 'display_name': 'Biohaven Pharmaceuticals (United States)', 'ror': 'https://ror.org/00m2ky193', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210093361']}, {'id': 'https://openalex.org/I150569930', 'display_name': 'Bayer (United States)', 'ror': 'https://ror.org/034ffbg36', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I150569930', 'https://openalex.org/I67348948']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Hong Rong', 'raw_affiliation_strings': ['1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and'], 'affiliations': [{'raw_affiliation_string': '1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and', 'institution_ids': ['https://openalex.org/I4210093361', 'https://openalex.org/I150569930']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5071015273', 'display_name': 'Charles Chen', 'orcid': 'https://orcid.org/0000-0002-2203-0433'}, 'institutions': [{'id': 'https://openalex.org/I4210093361', 'display_name': 'Biohaven Pharmaceuticals (United States)', 'ror': 'https://ror.org/00m2ky193', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210093361']}, {'id': 'https://openalex.org/I150569930', 'display_name': 'Bayer (United States)', 'ror': 'https://ror.org/034ffbg36', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I150569930', 'https://openalex.org/I67348948']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Charles Chen', 'raw_affiliation_strings': ['1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and'], 'affiliations': [{'raw_affiliation_string': '1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and', 'institution_ids': ['https://openalex.org/I4210093361', 'https://openalex.org/I150569930']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100353012', 'display_name': 'Xiaomei Zhang', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210093361', 'display_name': 'Biohaven Pharmaceuticals (United States)', 'ror': 'https://ror.org/00m2ky193', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210093361']}, {'id': 'https://openalex.org/I150569930', 'display_name': 'Bayer (United States)', 'ror': 'https://ror.org/034ffbg36', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I150569930', 'https://openalex.org/I67348948']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Xiaomei Zhang', 'raw_affiliation_strings': ['1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and'], 'affiliations': [{'raw_affiliation_string': '1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and', 'institution_ids': ['https://openalex.org/I4210093361', 'https://openalex.org/I150569930']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5065494091', 'display_name': 'Patrick W. Vincent', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210093361', 'display_name': 'Biohaven Pharmaceuticals (United States)', 'ror': 'https://ror.org/00m2ky193', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210093361']}, {'id': 'https://openalex.org/I150569930', 'display_name': 'Bayer (United States)', 'ror': 'https://ror.org/034ffbg36', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I150569930', 'https://openalex.org/I67348948']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Patrick Vincent', 'raw_affiliation_strings': ['1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and'], 'affiliations': [{'raw_affiliation_string': '1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and', 'institution_ids': ['https://openalex.org/I4210093361', 'https://openalex.org/I150569930']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5074681599', 'display_name': 'Mark McHugh', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210093361', 'display_name': 'Biohaven Pharmaceuticals (United States)', 'ror': 'https://ror.org/00m2ky193', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210093361']}, {'id': 'https://openalex.org/I150569930', 'display_name': 'Bayer (United States)', 'ror': 'https://ror.org/034ffbg36', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I150569930', 'https://openalex.org/I67348948']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mark McHugh', 'raw_affiliation_strings': ['1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and'], 'affiliations': [{'raw_affiliation_string': '1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and', 'institution_ids': ['https://openalex.org/I4210093361', 'https://openalex.org/I150569930']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5112782089', 'display_name': 'Yichen Cao', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210093361', 'display_name': 'Biohaven Pharmaceuticals (United States)', 'ror': 'https://ror.org/00m2ky193', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210093361']}, {'id': 'https://openalex.org/I150569930', 'display_name': 'Bayer (United States)', 'ror': 'https://ror.org/034ffbg36', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I150569930', 'https://openalex.org/I67348948']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Yichen Cao', 'raw_affiliation_strings': ['1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and'], 'affiliations': [{'raw_affiliation_string': '1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and', 'institution_ids': ['https://openalex.org/I4210093361', 'https://openalex.org/I150569930']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5091138690', 'display_name': 'Jaleel Shujath', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210093361', 'display_name': 'Biohaven Pharmaceuticals (United States)', 'ror': 'https://ror.org/00m2ky193', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210093361']}, {'id': 'https://openalex.org/I150569930', 'display_name': 'Bayer (United States)', 'ror': 'https://ror.org/034ffbg36', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I150569930', 'https://openalex.org/I67348948']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jaleel Shujath', 'raw_affiliation_strings': ['1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and'], 'affiliations': [{'raw_affiliation_string': '1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and', 'institution_ids': ['https://openalex.org/I4210093361', 'https://openalex.org/I150569930']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5048709159', 'display_name': 'Susan L. Gawlak', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210093361', 'display_name': 'Biohaven Pharmaceuticals (United States)', 'ror': 'https://ror.org/00m2ky193', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210093361']}, {'id': 'https://openalex.org/I150569930', 'display_name': 'Bayer (United States)', 'ror': 'https://ror.org/034ffbg36', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I150569930', 'https://openalex.org/I67348948']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Susan Gawlak', 'raw_affiliation_strings': ['1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and'], 'affiliations': [{'raw_affiliation_string': '1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and', 'institution_ids': ['https://openalex.org/I4210093361', 'https://openalex.org/I150569930']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5057284320', 'display_name': 'Deepa Eveleigh', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210093361', 'display_name': 'Biohaven Pharmaceuticals (United States)', 'ror': 'https://ror.org/00m2ky193', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210093361']}, {'id': 'https://openalex.org/I150569930', 'display_name': 'Bayer (United States)', 'ror': 'https://ror.org/034ffbg36', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I150569930', 'https://openalex.org/I67348948']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Deepa Eveleigh', 'raw_affiliation_strings': ['1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and'], 'affiliations': [{'raw_affiliation_string': '1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and', 'institution_ids': ['https://openalex.org/I4210093361', 'https://openalex.org/I150569930']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5089323323', 'display_name': 'Bruce R. Rowley', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210093361', 'display_name': 'Biohaven Pharmaceuticals (United States)', 'ror': 'https://ror.org/00m2ky193', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210093361']}, {'id': 'https://openalex.org/I150569930', 'display_name': 'Bayer (United States)', 'ror': 'https://ror.org/034ffbg36', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I150569930', 'https://openalex.org/I67348948']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Bruce Rowley', 'raw_affiliation_strings': ['1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and'], 'affiliations': [{'raw_affiliation_string': '1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and', 'institution_ids': ['https://openalex.org/I4210093361', 'https://openalex.org/I150569930']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100418899', 'display_name': 'Li Liu', 'orcid': 'https://orcid.org/0000-0003-2314-8756'}, 'institutions': [{'id': 'https://openalex.org/I4210093361', 'display_name': 'Biohaven Pharmaceuticals (United States)', 'ror': 'https://ror.org/00m2ky193', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210093361']}, {'id': 'https://openalex.org/I150569930', 'display_name': 'Bayer (United States)', 'ror': 'https://ror.org/034ffbg36', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I150569930', 'https://openalex.org/I67348948']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Li Liu', 'raw_affiliation_strings': ['1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and'], 'affiliations': [{'raw_affiliation_string': '1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and', 'institution_ids': ['https://openalex.org/I4210093361', 'https://openalex.org/I150569930']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5030911566', 'display_name': 'Lila Adnane', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I150569930', 'display_name': 'Bayer (United States)', 'ror': 'https://ror.org/034ffbg36', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I150569930', 'https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I4210093361', 'display_name': 'Biohaven Pharmaceuticals (United States)', 'ror': 'https://ror.org/00m2ky193', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210093361']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Lila Adnane', 'raw_affiliation_strings': ['1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and'], 'affiliations': [{'raw_affiliation_string': '1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and', 'institution_ids': ['https://openalex.org/I150569930', 'https://openalex.org/I4210093361']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5022430976', 'display_name': 'Mark Lynch', 'orcid': 'https://orcid.org/0000-0002-8476-4854'}, 'institutions': [{'id': 'https://openalex.org/I4210093361', 'display_name': 'Biohaven Pharmaceuticals (United States)', 'ror': 'https://ror.org/00m2ky193', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210093361']}, {'id': 'https://openalex.org/I150569930', 'display_name': 'Bayer (United States)', 'ror': 'https://ror.org/034ffbg36', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I150569930', 'https://openalex.org/I67348948']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mark Lynch', 'raw_affiliation_strings': ['1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and'], 'affiliations': [{'raw_affiliation_string': '1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and', 'institution_ids': ['https://openalex.org/I4210093361', 'https://openalex.org/I150569930']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5055000089', 'display_name': 'Daniel Auclair', 'orcid': 'https://orcid.org/0000-0001-5151-3058'}, 'institutions': [{'id': 'https://openalex.org/I4210093361', 'display_name': 'Biohaven Pharmaceuticals (United States)', 'ror': 'https://ror.org/00m2ky193', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210093361']}, {'id': 'https://openalex.org/I150569930', 'display_name': 'Bayer (United States)', 'ror': 'https://ror.org/034ffbg36', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I150569930', 'https://openalex.org/I67348948']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Daniel Auclair', 'raw_affiliation_strings': ['1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and'], 'affiliations': [{'raw_affiliation_string': '1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and', 'institution_ids': ['https://openalex.org/I4210093361', 'https://openalex.org/I150569930']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103076894', 'display_name': 'I Taylor', 'orcid': 'https://orcid.org/0009-0002-1572-9921'}, 'institutions': [{'id': 'https://openalex.org/I4210093361', 'display_name': 'Biohaven Pharmaceuticals (United States)', 'ror': 'https://ror.org/00m2ky193', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210093361']}, {'id': 'https://openalex.org/I150569930', 'display_name': 'Bayer (United States)', 'ror': 'https://ror.org/034ffbg36', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I150569930', 'https://openalex.org/I67348948']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ian Taylor', 'raw_affiliation_strings': ['1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and'], 'affiliations': [{'raw_affiliation_string': '1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and', 'institution_ids': ['https://openalex.org/I4210093361', 'https://openalex.org/I150569930']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5050022250', 'display_name': 'Rich Gedrich', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210093361', 'display_name': 'Biohaven Pharmaceuticals (United States)', 'ror': 'https://ror.org/00m2ky193', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210093361']}, {'id': 'https://openalex.org/I150569930', 'display_name': 'Bayer (United States)', 'ror': 'https://ror.org/034ffbg36', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I150569930', 'https://openalex.org/I67348948']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Rich Gedrich', 'raw_affiliation_strings': ['1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and'], 'affiliations': [{'raw_affiliation_string': '1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and', 'institution_ids': ['https://openalex.org/I4210093361', 'https://openalex.org/I150569930']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5041059002', 'display_name': 'Andrei Voznesensky', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210093361', 'display_name': 'Biohaven Pharmaceuticals (United States)', 'ror': 'https://ror.org/00m2ky193', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210093361']}, {'id': 'https://openalex.org/I150569930', 'display_name': 'Bayer (United States)', 'ror': 'https://ror.org/034ffbg36', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I150569930', 'https://openalex.org/I67348948']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Andrei Voznesensky', 'raw_affiliation_strings': ['1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and'], 'affiliations': [{'raw_affiliation_string': '1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and', 'institution_ids': ['https://openalex.org/I4210093361', 'https://openalex.org/I150569930']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5006281057', 'display_name': 'Bernd Riedl', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I150569930', 'display_name': 'Bayer (United States)', 'ror': 'https://ror.org/034ffbg36', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I150569930', 'https://openalex.org/I67348948']}, {'id': 'https://openalex.org/I4210093361', 'display_name': 'Biohaven Pharmaceuticals (United States)', 'ror': 'https://ror.org/00m2ky193', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210093361']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Bernd Riedl', 'raw_affiliation_strings': ['1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and'], 'affiliations': [{'raw_affiliation_string': '1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and', 'institution_ids': ['https://openalex.org/I150569930', 'https://openalex.org/I4210093361']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5085037854', 'display_name': 'Leonard Post', 'orcid': 'https://orcid.org/0009-0007-5779-4146'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Leonard E. Post', 'raw_affiliation_strings': ['2Onyx Pharmaceuticals, Richmond, California'], 'affiliations': [{'raw_affiliation_string': '2Onyx Pharmaceuticals, Richmond, California', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5069230508', 'display_name': 'Gideon Bollag', 'orcid': 'https://orcid.org/0000-0002-1824-6194'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Gideon Bollag', 'raw_affiliation_strings': ['2Onyx Pharmaceuticals, Richmond, California'], 'affiliations': [{'raw_affiliation_string': '2Onyx Pharmaceuticals, Richmond, California', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5058577237', 'display_name': 'Pamela A. Trail', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210093361', 'display_name': 'Biohaven Pharmaceuticals (United States)', 'ror': 'https://ror.org/00m2ky193', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210093361']}, {'id': 'https://openalex.org/I150569930', 'display_name': 'Bayer (United States)', 'ror': 'https://ror.org/034ffbg36', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I150569930', 'https://openalex.org/I67348948']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Pamela A. Trail', 'raw_affiliation_strings': ['1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and'], 'affiliations': [{'raw_affiliation_string': '1Bayer Pharmaceuticals Corporation, West Haven, Connecticut; and', 'institution_ids': ['https://openalex.org/I4210093361', 'https://openalex.org/I150569930']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 3, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 51.442, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 3876, 'citation_normalized_percentile': {'value': 0.999979, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 99, 'max': 100}, 'biblio': {'volume': '64', 'issue': '19', 'first_page': '7099', 'last_page': '7109'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11533', 'display_name': 'Melanoma and MAPK Pathways', 'score': 0.9997, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11533', 'display_name': 'Melanoma and MAPK Pathways', 'score': 0.9997, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10169', 'display_name': 'Protein Kinase Regulation and GTPase Signaling', 'score': 0.9941, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11503', 'display_name': 'Cytokine Signaling Pathways and Interactions', 'score': 0.994, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.67663074}, {'id': 'https://openalex.org/C101544691', 'wikidata': 'https://www.wikidata.org/wiki/Q420511', 'display_name': 'Receptor tyrosine kinase', 'level': 3, 'score': 0.65574455}, {'id': 'https://openalex.org/C57074206', 'wikidata': 'https://www.wikidata.org/wiki/Q14197552', 'display_name': 'MAPK/ERK pathway', 'level': 3, 'score': 0.6504607}, {'id': 'https://openalex.org/C2781249067', 'wikidata': 'https://www.wikidata.org/wiki/Q17142288', 'display_name': 'MEK inhibitor', 'level': 4, 'score': 0.46725628}, {'id': 'https://openalex.org/C2781187634', 'wikidata': 'https://www.wikidata.org/wiki/Q20969980', 'display_name': 'KRAS', 'level': 4, 'score': 0.46416193}, {'id': 'https://openalex.org/C2780394083', 'wikidata': 'https://www.wikidata.org/wiki/Q539568', 'display_name': 'Angiogenesis', 'level': 2, 'score': 0.46323535}, {'id': 'https://openalex.org/C26375932', 'wikidata': 'https://www.wikidata.org/wiki/Q118226', 'display_name': 'Growth factor receptor', 'level': 3, 'score': 0.45431682}, {'id': 'https://openalex.org/C62478195', 'wikidata': 'https://www.wikidata.org/wiki/Q828130', 'display_name': 'Signal transduction', 'level': 2, 'score': 0.44431022}, {'id': 'https://openalex.org/C184235292', 'wikidata': 'https://www.wikidata.org/wiki/Q421851', 'display_name': 'Kinase', 'level': 2, 'score': 0.44114676}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.4162323}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.40903705}, {'id': 'https://openalex.org/C95444343', 'wikidata': 'https://www.wikidata.org/wiki/Q7141', 'display_name': 'Cell biology', 'level': 1, 'score': 0.25180778}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.20610774}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.20365325}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.20312107}, {'id': 'https://openalex.org/C526805850', 'wikidata': 'https://www.wikidata.org/wiki/Q188874', 'display_name': 'Colorectal cancer', 'level': 3, 'score': 0.06975451}], 'mesh': [{'descriptor_ui': 'D001557', 'descriptor_name': 'Benzenesulfonates', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D048728', 'descriptor_name': 'MAP Kinase Kinase Kinase 1', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D020935', 'descriptor_name': 'MAP Kinase Signaling System', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D020928', 'descriptor_name': 'Mitogen-Activated Protein Kinases', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D009369', 'descriptor_name': 'Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D009369', 'descriptor_name': 'Neoplasms', 'qualifier_ui': 'Q000201', 'qualifier_name': 'enzymology', 'is_major_topic': True}, {'descriptor_ui': 'D011725', 'descriptor_name': 'Pyridines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D020794', 'descriptor_name': 'Receptor Protein-Tyrosine Kinases', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D040262', 'descriptor_name': 'Receptors, Vascular Endothelial Growth Factor', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D000284', 'descriptor_name': 'Administration, Oral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001557', 'descriptor_name': 'Benzenesulfonates', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D045744', 'descriptor_name': 'Cell Line, Tumor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018450', 'descriptor_name': 'Disease Progression', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020930', 'descriptor_name': 'MAP Kinase Kinase Kinases', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D020930', 'descriptor_name': 'MAP Kinase Kinase Kinases', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D020930', 'descriptor_name': 'MAP Kinase Kinase Kinases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020935', 'descriptor_name': 'MAP Kinase Signaling System', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051379', 'descriptor_name': 'Mice', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008819', 'descriptor_name': 'Mice, Nude', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019950', 'descriptor_name': 'Mitogen-Activated Protein Kinase 1', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019950', 'descriptor_name': 'Mitogen-Activated Protein Kinase 1', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D019950', 'descriptor_name': 'Mitogen-Activated Protein Kinase 1', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D048052', 'descriptor_name': 'Mitogen-Activated Protein Kinase 3', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020928', 'descriptor_name': 'Mitogen-Activated Protein Kinases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020928', 'descriptor_name': 'Mitogen-Activated Protein Kinases', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D009369', 'descriptor_name': 'Neoplasms', 'qualifier_ui': 'Q000098', 'qualifier_name': 'blood supply', 'is_major_topic': False}, {'descriptor_ui': 'D009369', 'descriptor_name': 'Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009389', 'descriptor_name': 'Neovascularization, Pathologic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009389', 'descriptor_name': 'Neovascularization, Pathologic', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D009389', 'descriptor_name': 'Neovascularization, Pathologic', 'qualifier_ui': 'Q000201', 'qualifier_name': 'enzymology', 'is_major_topic': False}, {'descriptor_ui': 'D009536', 'descriptor_name': 'Niacinamide', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009536', 'descriptor_name': 'Niacinamide', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': False}, {'descriptor_ui': 'D010671', 'descriptor_name': 'Phenylurea Compounds', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019908', 'descriptor_name': 'Proto-Oncogene Proteins c-raf', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D019908', 'descriptor_name': 'Proto-Oncogene Proteins c-raf', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D019908', 'descriptor_name': 'Proto-Oncogene Proteins c-raf', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011725', 'descriptor_name': 'Pyridines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020794', 'descriptor_name': 'Receptor Protein-Tyrosine Kinases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020794', 'descriptor_name': 'Receptor Protein-Tyrosine Kinases', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D040262', 'descriptor_name': 'Receptors, Vascular Endothelial Growth Factor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077157', 'descriptor_name': 'Sorafenib', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D023041', 'descriptor_name': 'Xenograft Model Antitumor Assays', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/0008-5472.can-04-1443', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/15466206', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.57}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 36, 'referenced_works': ['https://openalex.org/W1868766650', 'https://openalex.org/W1933537883', 'https://openalex.org/W1965343041', 'https://openalex.org/W1983064145', 'https://openalex.org/W1984375602', 'https://openalex.org/W1985035689', 'https://openalex.org/W1986283944', 'https://openalex.org/W1987821958', 'https://openalex.org/W2000076269', 'https://openalex.org/W2028415754', 'https://openalex.org/W2029580509', 'https://openalex.org/W2041687747', 'https://openalex.org/W2044498188', 'https://openalex.org/W2046507292', 'https://openalex.org/W2048983596', 'https://openalex.org/W2050085273', 'https://openalex.org/W2052550764', 'https://openalex.org/W2057283586', 'https://openalex.org/W2061203237', 'https://openalex.org/W2062138347', 'https://openalex.org/W2064991073', 'https://openalex.org/W2083400761', 'https://openalex.org/W2098419457', 'https://openalex.org/W2102056525', 'https://openalex.org/W2118033606', 'https://openalex.org/W2118559000', 'https://openalex.org/W2123334268', 'https://openalex.org/W2124662474', 'https://openalex.org/W2134755472', 'https://openalex.org/W2144785546', 'https://openalex.org/W2155299791', 'https://openalex.org/W2163188200', 'https://openalex.org/W2165057712', 'https://openalex.org/W2597626829', 'https://openalex.org/W4211075026', 'https://openalex.org/W4253705647'], 'related_works': ['https://openalex.org/W4318612407', 'https://openalex.org/W4307910990', 'https://openalex.org/W4281763928', 'https://openalex.org/W4226207639', 'https://openalex.org/W2770034320', 'https://openalex.org/W2487850446', 'https://openalex.org/W2320994390', 'https://openalex.org/W2110980999', 'https://openalex.org/W2109132296', 'https://openalex.org/W1990511191'], 'abstract_inverted_index': {'The': [0, 14], 'RAS/RAF': [1], 'signaling': [2, 31], 'pathway': [3, 96, 131, 208], 'is': [4, 20, 250], 'an': [5], 'important': [6], 'mediator': [7], 'of': [8, 24, 28, 91, 126, 137, 159, 182, 187, 197, 205, 217, 235, 240], 'tumor': [9, 65, 102, 183, 226, 262, 266], 'cell': [10, 103, 117, 263], 'proliferation': [11, 264], 'and': [12, 42, 64, 81, 100, 144, 169, 185, 220, 257, 265], 'angiogenesis.': [13, 267], 'novel': [15, 252], 'bi-aryl': [16], 'urea': [17], 'BAY': [18, 37, 51, 87, 133, 153, 160, 248], '43-9006': [19, 38, 52, 88, 161, 249], 'a': [21, 26, 177, 251], 'potent': [22], 'inhibitor': [23, 259], 'Raf-1,': [25], 'member': [27], 'the': [29, 92, 127, 188, 206, 224, 241], 'RAF/MEK/ERK': [30, 207], 'pathway.': [32], 'Additional': [33, 215], 'characterization': [34], 'showed': [35], 'that': [36, 247, 260], 'suppresses': [39], 'both': [40], 'wild-type': [41, 109], 'V599E': [43], 'mutant': [44, 106, 111, 120], 'BRAF': [45], 'activity': [46, 55, 165], 'in': [47, 62, 97, 166, 195, 209, 223, 237], 'vitro.': [48], 'In': [49, 83], 'addition,': [50], 'demonstrated': [53, 89, 162, 176, 232], 'significant': [54, 233], 'against': [56], 'several': [57], 'receptor': [58, 72, 78, 142, 147], 'tyrosine': [59], 'kinases': [60, 191], 'involved': [61], 'neovascularization': [63, 236], 'progression,': [66], 'including': [67], 'vascular': [68], 'endothelial': [69], 'growth': [70, 76, 140, 184], 'factor': [71, 77, 141], '(VEGFR)-2,': [73], 'VEGFR-3,': [74], 'platelet-derived': [75, 139], 'beta,': [79, 143], 'Flt-3,': [80], 'c-KIT.': [82], 'cellular': [84, 146], 'mechanistic': [85], 'assays,': [86], 'inhibition': [90, 125, 136, 181, 186, 204, 234], 'mitogen-activated': [93, 128], 'protein': [94, 129], 'kinase': [95, 130, 256], 'colon,': [98, 167], 'pancreatic,': [99], 'breast': [101], 'lines': [104, 118], 'expressing': [105, 119], 'KRAS': [107, 121], 'or': [108, 110], 'BRAF,': [112], 'whereas': [113], 'non-small-cell': [114, 170], 'lung': [115, 171], 'cancer': [116, 172], 'were': [122], 'insensitive': [123], 'to': [124], 'by': [132], '43-9006.': [134, 154], 'Potent': [135], 'VEGFR-2,': [138], 'VEGFR-3': [145], 'autophosphorylation': [148], 'was': [149], 'also': [150], 'observed': [151], 'for': [152], 'Once': [155], 'daily': [156], 'oral': [157], 'dosing': [158], 'broad-spectrum': [163], 'antitumor': [164], 'breast,': [168], 'xenograft': [173, 199, 242], 'models.': [174, 214, 243], 'Immunohistochemistry': [175], 'close': [178], 'association': [179], 'between': [180], 'extracellular': [189], 'signal-regulated': [190], '(ERKs)': [192], '1/2': [193], 'phosphorylation': [194], 'two': [196], 'three': [198, 239], 'models': [200], 'examined,': [201], 'consistent': [202], 'with': [203], 'some': [210], 'but': [211], 'not': [212], 'all': [213, 238], 'analyses': [216], 'microvessel': [218, 221], 'density': [219], 'area': [222], 'same': [225], 'sections': [227], 'using': [228], 'antimurine': [229], 'CD31': [230], 'antibodies': [231], 'These': [244], 'data': [245], 'demonstrate': [246], 'dual': [253], 'action': [254], 'RAF': [255], 'VEGFR': [258], 'targets': [261]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2140765540', 'counts_by_year': [{'year': 2024, 'cited_by_count': 94}, {'year': 2023, 'cited_by_count': 151}, {'year': 2022, 'cited_by_count': 137}, {'year': 2021, 'cited_by_count': 168}, {'year': 2020, 'cited_by_count': 149}, {'year': 2019, 'cited_by_count': 134}, {'year': 2018, 'cited_by_count': 150}, {'year': 2017, 'cited_by_count': 197}, {'year': 2016, 'cited_by_count': 184}, {'year': 2015, 'cited_by_count': 203}, {'year': 2014, 'cited_by_count': 265}, {'year': 2013, 'cited_by_count': 265}, {'year': 2012, 'cited_by_count': 296}], 'updated_date': '2025-01-08T09:59:20.966554', 'created_date': '2016-06-24'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
